Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERTOLIZUMAB PEGOL for Psoriatic arthropathy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10,537 adverse event reports in the FDA FAERS database where CERTOLIZUMAB PEGOL was used for Psoriatic arthropathy.

Most Reported Side Effects for CERTOLIZUMAB PEGOL

Side Effect Reports % Deaths Hosp.
Drug ineffective 23,838 24.1% 1,165 3,601
Rheumatoid arthritis 17,782 17.9% 1,735 3,510
Pain 13,929 14.1% 1,494 2,958
Fatigue 11,438 11.5% 1,764 3,013
Off label use 10,281 10.4% 1,629 3,112
Rash 9,663 9.8% 1,679 2,832
Alopecia 9,111 9.2% 1,589 2,504
Maternal exposure during pregnancy 9,013 9.1% 1,288 2,039
Arthralgia 8,993 9.1% 1,591 2,928
Abdominal discomfort 8,615 8.7% 1,581 2,564
Joint swelling 8,607 8.7% 1,690 2,643
Systemic lupus erythematosus 8,212 8.3% 1,760 2,351
Pemphigus 7,869 7.9% 1,564 2,114
Contraindicated product administered 7,783 7.9% 1,059 2,122
Swelling 7,748 7.8% 1,641 2,419

Other Indications for CERTOLIZUMAB PEGOL

Rheumatoid arthritis (47,602) Product used for unknown indication (19,011) Crohn's disease (8,758) Psoriasis (8,179) Ankylosing spondylitis (7,776) Off label use (2,256) Axial spondyloarthritis (1,313) Colitis ulcerative (432) Juvenile idiopathic arthritis (385) Spondyloarthropathy (309)

Other Drugs Used for Psoriatic arthropathy

ADALIMUMAB (47,183) ETANERCEPT (39,876) SECUKINUMAB (38,507) APREMILAST (33,990) METHOTREXATE (6,997) RISANKIZUMAB-RZAA (6,970) TOFACITINIB (6,384) USTEKINUMAB (5,909) IXEKIZUMAB (5,798) GOLIMUMAB (5,477)

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Psoriatic arthropathy Drugs CERTOLIZUMAB PEGOL Demographics CERTOLIZUMAB PEGOL Timeline